Sanofi halted clinical trials of Kevzara as a treatment for COVID-19.
Dr. Stephen Hahn told the Financial Times a vaccine developer could receive federal approval before phase three trials are complete if the benefits outweigh the risks. » Subscribe to NBC News: » Watch more NBC video: NBC News Digital is…
Last week the Australian Government announced an arrangement which could allow this country to manufacture a vaccine developed at the University of Oxford. There’s still a long way to go before it becomes a reality, and not too far behind…